Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Relevant leaders from the Hebei Provincial Health and Family Planning Commission visited our company to inspect and guide the work.
Release Time:
2018-08-25
On August 24th, relevant leaders from the Hebei Provincial Health and Family Planning Commission, accompanied by leaders from the Weixian County Health and Family Planning Bureau, visited our company for inspection and guidance. During the visit, the company's General Manager Dong Yihong received them and provided a detailed introduction to the company's business development. He led the leaders and experts on a field tour of the company's blood perfusion resin research and development center. Both parties had extensive exchanges regarding the construction of the blood perfusion device project and product applications. Our blood perfusion project received full recognition from the leaders and experts present.
Keyword:
Recommended Reading
24-05-14 14:37:56
